まとめ
ゴールデンハムスターは,細胞抵抗性のためにコルキシンに反応しない. この耐性により,コルチキンのインビボ試験が可能です.
科学分野:
- 薬理学と毒理学について
- がん研究 がん研究
背景:
- コルヒシンは強力な抗真菌剤です.
- ゴールデンハムスターは,コルチキンの毒性効果に対する固有の抵抗性を示す.
研究 の 目的:
- ゴールデンハムスターのコルキシン抵抗性の細胞基盤を調査するために.
- 異種移植された腫瘍を用いたコルチシンの有効性研究のためのモデルを確立する.
主な方法:
- コルキシンに対する細胞抵抗の測定.
- 腫瘍を黄金のハムスターに異種移植する.
- 腫瘍応答と宿主毒性を評価するために,コルキシンを体内で投与する.
主要な成果:
- 個々の黄金のハムスターの細胞は,コルキシンに対する有意な耐性を示しています.
- コルキシンで治療されたハムスターの異種移植腫瘍は,抗腫瘍効果を示した.
- ゴールデンハムスターでは有意な有毒宿主反応は観察されなかった.
結論:
- ゴールデンハムスターのコルキシンに対する細胞抵抗性が確認されました.
- この抵抗は,全身の毒性なしにコルヒシンの in vivo 抗腫瘍活動を評価するためのユニークなモデルを提供します.
- このモデルは,コルキシンベースの治療法の臨床前試験に適しています.
キーワード:
COLCHICINE/効果についてさらに関連する動画
12:03Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
関連する概念動画
Antibiotic Selection
Overview
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
